INTRODUCTION
============

Endoscopic mucosal resection (EMR) has been widely used to treat colorectal polyps because of its attractive clinical advantages including simplicity, speed, and low complication rate.[@B1],[@B2],[@B3],[@B4],[@B5],[@B6],[@B7] However, piecemeal resection frequently occurred in polyps exceeding 20 mm in diameter (49% to 100%),[@B8],[@B9],[@B10] and the local recurrence of polyps resected in this manner has been reported to be 25% to 50%, compared with a value of 7.7% to 21.9% for *en bloc* resection.[@B11],[@B12]

As endoscopic submucosal dissection (ESD) has been reported to achieve high *en bloc* resection rates (84%)[@B13] and low recurrence rates in the colorectum, it is expected to overcome the limitations of EMR and offer better clinical outcomes.[@B14] ESD is a modified form of EMR, and has been established as a standard technique for the treatment of early gastric cancers and adenomas. On the other hand, ESD has not yet been established as a standard intervention in the colorectum due to its unique organ-specific characteristics, technical difficulty, and high complication rate. To overcome these drawbacks, modified endoscopic procedures have been introduced, such as ESD with snaring and EMR with circumferential incision (EMR-CI).[@B15],[@B16],[@B17]

EMR-CI was first reported by Hirao et al.[@B18] in 1986, and has been used to endoscopically treat early gastric cancers. Several studies have reported high *en bloc* resection rates (55.1% to 68.0%) and low recurrence rates (0.0% to 17.8%) for EMR-CI in cases involving large colorectal polyps.[@B17],[@B19],[@B20] Therefore, EMR-CI may offer similar clinical outcomes to ESD, and may even provide additional advantages such as relatively simple technique and shorter procedure times. The aim of the present study was to evaluate the efficacy and safety of EMR-CI for the treatment of large (≥20 mm diameter) sessile polyps (Is) and laterally spreading tumors (LSTs) in the colorectum.

MATERIALS AND METHODS
=====================

Patients
--------

This study was performed in patients who were diagnosed with large (≥20 mm diameter) colorectal polyps and treated by EMR-CI at Pusan National University Yangsan Hospital between February 2009 and March 2011. A total of 80 patients were enrolled, of which 13 had Is polyps and 67 had LSTs. Exclusion criteria were the presence of colorectal polyps with stalks, or endoscopic findings of deep submucosal invasion such as ulceration, firm consistency, friability, and spontaneous bleeding. Written informed consent was obtained from all patients, and the study was approved by the Institutional Review Board of Pusan National University Yangsan Hospital (PNUYH IRB No. 05-2014-028).

Classification of lesion morphology and location
------------------------------------------------

Lesions were classified as either 1) Is polyps, which are protrusion lesions with a height of ≥2.5 mm; or 2) LSTs, which are superficial and elevated lesions with a height of \<2.5 mm and a lateral diameter of \>10 mm, and classified into two subgroups, namely granular (LST-Gs) and non-granular (LST-NGs).[@B21] The right colon included the cecum, and the ascending and transverse colon. The left colon included the descending and sigmoid colon.

Endoscopic procedure
--------------------

For colonic preparation, we used 4 L of polyethylene glycol solution on the day of the procedure, or as a divided dose during the day before the procedure and on the day of the procedure. A single-channel colonoscope (CF-H260AI; Olympus Optical Co., Tokyo, Japan) or a single-channel upper endoscope (GIF-H260; Olympus Optical Co.) and a high-frequency generator with an automatically controlled system (VIO300; ERBE Elektromedizin GmbH, Tübingen, Germany) were used for EMR-CI. We used the electrosurgical units as follows: CI, dry cut (effect-2, 30 W); snare resection mode, endocut Q (effect-1, cut duration-1, cut interval-3); coagulation mode; and soft coagulation (effect-5, 50 W). A cap-pitted endoscope with a transparent attachment (D-201-11804 or D-201-14304; Olympus Optical Co.) was used in all procedures. A mixed solution of glycerol (10% glycerin and 5% fructose injection; CJ Pharma, Seoul Korea), epinephrine, and indigo carmine was used for submucosal injection. Endoscopic procedures were performed by an endoscopist who was highly experienced (10 years) in diagnostic and therapeutic colonoscopy, and who had a history of performing more than 500 EMR procedures per year. After sufficient injection into the peripheral submucosa of the polyp, CI was performed 2 mm away from the polyp using a dual knife (Olympus KD-650D), and additional trimming was performed to allow easy snaring. The polyp was then resected using a 25 or 35 mm oval snare ([Fig. 1](#F1){ref-type="fig"}). Piecemeal resection was performed in cases where snaring was difficult due to large polyp size or difficult polyp location after CI ([Fig. 2](#F2){ref-type="fig"}). If residual polyp tissue was suspected after *en bloc* resection, ablation and removal were performed using hot biopsy. For piecemeal resection, ablation and removal were performed using hot biopsy in all cases. All patients were admitted on the day before the procedure, and unless complications occurred, they were discharged 2 days after EMR-CI. Follow-up colonoscopy was performed 3 to 6 months after the procedure, depending on the margin status or polyp histology, and again after 1 to 2 years to assess local recurrence. We evaluated post-EMR-CI scarring by narrow band imaging or indigo carmine spraying, and a biopsy was performed if recurrence was suspected.

Pathologic evaluation
---------------------

All resected specimens were fixed in 10% formalin, cut into 2-mm slices, and microscopically evaluated for histologic type, depth of invasion, and lateral and vertical cut margins. We defined complete endoscopic resection as the complete removal of endoscopically visible tumor regardless of *en bloc* resection. Histologically complete resection was defined as the presence of lateral and vertical margins free of adenoma and adenocarcinoma, independent of the histologic features. In addition, the depth of submucosal invasion, lymphovascular invasion, and tumor budding were evaluated. If the cancer invaded deeper than 1,000 µM into the submucosa, or had unfavorable pathologic features (lymphovascular invasion, poor differentiation, or tumor budding), radical surgery was recommended.

Statistical analysis
--------------------

All values in this study are presented as medians (range). Comparisons were made using the chi-square test, Fisher exact test, and Student *t*-test. *p*-values of \<0.05 were considered to be statistically significant. All statistical analyses were performed using the SPSS 18.0 version (SPSS Inc., Chicago, IL, USA).

RESULTS
=======

From February 2009 to March 2011, we performed EMR-CI on 80 colorectal polyps. Fifty-one of 80 patients (63.8%) were male, and the median age (range) was 60 years (range, 33 to 82). The median diameter of polyps was 25 mm (range, 20 to 50), and more than half of the polyps were located in the right colon. Morphologically, lesions were classified as Is (*n*=13), LST-G (*n*=37), and LST-NG (*n*=30). Two cases involved polyps located in the cecum, and both of these were LST-Gs. According to histological findings after EMR-CI, 50% of the patients had advanced pathology because of large polyp size; high-grade dysplasia (20/80, 25%), mucosal cancer (18/80, 22.5%), and submucosal cancer (2/80, 2.5%).

Clinicopathologic characteristics according to polyp morphology are shown in [Table 1](#T1){ref-type="table"}. The sizes and histologic findings of polyps were not significantly different according to polyp morphology. However, Is polyps showed a tendency for larger size (≥30 mm diameter in 7/13, 53.8%), and the polyp location between different tumor morphologies was significantly different; Is polyps were mostly located in the rectum (9/13, 69.2%), and LST-Gs and LST-NGs were mostly located in the right colon (25/37, 67.6%; and 25/30, 83.3%; *p*\<0.01).

The clinical outcomes of endoscopic treatment are shown in [Table 2](#T2){ref-type="table"}. EMR-CI was successfully performed in all patients; complete endoscopic resection was performed (79/80, 98.8%) in all patents except in one who required additional surgery due to deep submucosal invasion (depth of submucosal invasion, 2,375 µM) identified in the post-EMR specimen. The *en bloc* resection rate was 66.3% (53/80), and the complete histologic resection rate was 45.0% (36/80). Local recurrence was not observed in any case. Although we could not identify an accurate rate of hot biopsy ablation due to the retrospective nature of the study, we assumed that was more than 33.7% because hot biopsy ablation was performed in all cases of piecemeal resection. With regard to complications, only perforation occurred, and this was identified in five patients (6.3%). The characteristics of polyps in patients with perforation were as follows: polyp sizes ranged from 25 to 40 mm; polyp morphologies were Is (*n*=1), LST-G (*n*=1), and LST-NG (*n*=3); and polyps were located in the transverse colon (*n*=3) and hepatic flexure (*n*=2). Among patients with perforation, the perforation occurred after snaring in four cases and during CI in one case, and *en bloc* resection was performed in three cases. All cases with perforation underwent endoscopic closure with hemoclips, and patients then fasted for 7 days and were maintained by parenteral nutrition and broad-spectrum intravenous antibiotics. A liquid diet was permitted 7 days after EMR if patients did not experience worsening of symptoms or fever, and the patients were discharged 10 days after EMR.

The clinical characteristics between *en bloc* and piecemeal resection are summarized in [Table 3](#T3){ref-type="table"}. The majority of *en bloc*-resected tumors were \<30 mm in diameter (41/53, 77.4%), and the size of polyps between the cases undergoing *en bloc* and piecemeal resection was significantly different (*p*\<0.01). However, the locations and morphologies of polyps were not significantly different between the two groups.

DISCUSSION
==========

This study aimed to evaluate the clinical outcomes of EMR-CI for the treatment of large Is polyps and LSTs in the colorectum. The rate of successful endoscopic removal was 100% despite the median lesion size of 25 mm. In our study, the *en bloc* resection rate was 66.3% (53/80), which was superior to that of conventional EMR (reported as 7% to 34% for large sessile polyps),[@B22],[@B23] and was comparable to other studies of EMR-CI, which have reported *en bloc* resection rates ranging from 55.1% to 68%.[@B17],[@B19],[@B20] Furthermore, when we evaluated clinical characteristics between *en bloc* and piecemeal resection, only polyp size was found to influence the *en bloc* resection rate, especially in polyps ≤30 mm in diameter. This result means that EMR-CI can be used to achieve *en bloc* resection regardless of tumor morphology and location if the polyp size is \<30 mm.

Achieving clear resection margins without tumorous tissue in the specimen margins is the most desirable goal of curative procedures. In contrast with gastric tumors, peritumoral marking before endoscopic incision is not commonly required for colorectal polyps since the margin of colorectal polyps can be clearly recognized. In our study, the complete histologic resection rate was only 45%, even though the *en bloc* resection rate was 66.3%. This result was different from those of two different studies on EMR-CI, which reported complete histologic resection rates of 17% and 59.4%.[@B19],[@B20] This difference can be explained by the safety margins used in each study. We, as well as Sakamoto et al.,[@B19] performed marginal incision 2 mm away from the polyp during CI, while Lee et al.[@B20] performed marginal incision 5 to 10 mm away from the polyp. These different methods may influence the complete histologic resection rate of EMR-CI. Furthermore, the low complete histologic resection rate was related to thermal injury of the marginal tissue, which occurred during CI and trimming; moreover, marginal tissue easily chipped off during the fixation of resected lesions. Therefore, smaller safety margins may cause unintended results such as positive or indefinite resection margins in pathological reports despite complete resection. However, low complete histologic resection rates are not always related to high recurrence rates. This observation might explain the low local recurrence rate or lack of local recurrence despite the low complete histologic resection rate in our study and that of Sakamoto et al.[@B19]

Complications such as early or delayed bleeding and postpolypectomy coagulation syndrome did not occur in any of the patients. However, perforation developed in five patients (5/80, 6.3%). Previous studies have reported perforation rates ranging from 0% to 1.2% for EMR and 1.4% to 10.4% for ESD.[@B5],[@B9],[@B23] Our perforation rate was higher than those of previous studies with EMR-CI, ranging from 0% to 3.5%.[@B17],[@B19],[@B20] This high perforation rate may be related to the location of tumors and the use of glycerol solution instead of sodium hyaluronate for submucosal lifting. Among the five cases, four perforations occurred after snaring and one perforation occurred during CI ([Fig. 3](#F3){ref-type="fig"}). Perforation occurring after snaring could be related to inadequate lifting of the central portion of the polyp, especially if the lesion was located on a fold. Perforation in such cases might occur more frequently because the proper muscle layer may be easily grasped during snaring if the polyp is located on a fold. Furthermore, glycerol solution is less effective at submucosal lifting than sodium hyaluronate, which is widely known to provide excellent height and duration of lifting after submucosal injection. Because we did not use sodium hyaluronate solution for submucosal injection, we believe that inadequate lifting contributed to the relatively high perforation rate. Therefore, adequate lifting using sodium hyaluronate solution may be required to prevent perforation in EMR-CI, especially in cases of tumors located on folds.

Local recurrence did not develop in any of our cases. EMR-CI can overcome the problems of positive lateral margins associated with EMR and can help clean up remnants of the lesion or normal mucosa within the incision line after CI. This result is supported by previous studies, which have reported similar local recurrence rates ranging from 0% to 17.8%.[@B17],[@B19],[@B20] Because the target lesion, including an adequate safety margin, can be clearly identified by CI before snaring in EMR-CI, it is more likely that complete histologic resection will occur with this technique. Moreover, the low recurrence rate in our report is explained by the fact that we removed all grossly remnant mucosa within the incision line by hot biopsy after EMR-CI. Because other reports also had short follow-up periods ranging from 6 to 16 months, we do not believe that our follow-up period was too short in comparison.[@B17],[@B19],[@B20] However, the short follow-up period in our study may have influenced the recurrence rate. Intensive and long follow-up endoscopic surveillance has been advocated after EMR, with average colonoscopy surveillance intervals of 3, 6, and 12 months.[@B24]

Recent advances in endoscopic technique have enabled the development of procedures such as endoscopic piecemeal mucosal resection (EPMR) and ESD for the removal of large polyps. The mean procedure times for EPMR[@B13],[@B25] and ESD[@B14],[@B25] range from 29 to 55 minutes, and from 70.5 to 108 minutes, respectively. With regard to the complications, the perforation rates for EPMR[@B11],[@B25],[@B26] and ESD[@B13],[@B14],[@B25] range from 0.8% to 1.3% and 6.2% to 10.0%, respectively. However, Saito et al.[@B25] reported that EPMR resulted in a higher recurrence rate compared with ESD (14% vs. 2%). The procedure time for EMR-CI in our report (22 minutes \[range, 7 to 60\]) was shorter than that of ESD, and the perforation rate was not considerably higher than that of ESD. Although our study reported a considerably high *en bloc* resection rate, and low complication and recurrence rates for ESD, we believe that if EMR-CI procedure experiences are accumulated, the clinical outcomes such as *en bloc* resection rate, complication rate, and recurrence rate will be better than those of ESD.[@B27] Although we could not analyze our results statistically, we could identify increasing trends of *en bloc* resection rates and decreasing trends of perforation rates over time.

This study had two limitations. First, since it was a retrospective study based on historical controls treated during different periods, several biases including selection bias may be present. Second, the number of patients included in this study and the follow-up duration were limited. As the median follow-up was 23 months, tumor recurrence may have been underestimated.

In conclusion, although the perforation rate was higher than that of ESD, EMR-CI may be an effective technique for the treatment of large (≥20 mm diameter) Is polyps and LSTs in the colorectum, based on the finding that similar clinical outcomes are noted. In particular, EMR-CI is a more simple technique and allows shorter procedure times. Although EMR-CI for 20 to 30 mm-sized colorectal polyps can achieve high *en bloc* resection rates while avoiding perforation and piecemeal resection, ESD may be the preferred method for \>30 mm-sized colorectal polyps that can be resected piecemeally. However, EMR-CI may be considered as a second line therapeutic option if ESD is difficult.
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![Endoscopic mucosal resection with circumferential incision (EMR-CI). (A) A laterally spreading tumor, granular type was noted. (B) After submucosal injection of glycerol, a circumferential incision was performed. (C) Mucosal resection by snare was performed. (D) Successful EMR-CI was achieved.](ce-48-52-g001){#F1}

![Endoscopic mucosal resection with circumferential incision and piecemeal resection. (A) A laterally spreading tumor, granular type was noted. (B) After submucosal injection of glycerol, a circumferential incision was performed. (C) After circumferential incision, piecemeal resection was first performed in the large, nodular section. (D) Remnant tumor tissue was sequentially resected with piecemeal technique. (E) Successful piecemeal resection was achieved.](ce-48-52-g002){#F2}

![Perforation caused by endoscopic mucosal resection with circumferential incision. (A) Perforation after snare resection was observed. (B) Perforation during circumferential incision was observed.](ce-48-52-g003){#F3}

###### 

Clinicopathologic Characteristics according to Polyp Morphology
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Values are presented as number (%).

Is, sessile polyp; LST-G, laterally spreading tumor-granular type; LST-NG, laterally spreading tumor-nongranular type; LGD, low grade dysplasia; HGD, high grade dysplasia.
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Clinical Outcomes for Endoscopic Treatment
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Values are presented as number (%) or median (range).

###### 

Clinical Characteristics between *En bloc* Resection and Piecemeal Resection
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Values are presented as number (%).

Is, sessile polyp; LST-G, laterally spreading tumor-granular type; LST-NG, laterally spreading tumor-nongranular type.
